UnitedHealth Group Incorporated (NYSE:UNH - Get Free Report) dropped 10.2% during mid-day trading on Wednesday. The stock traded as low as $342.46 and last traded at $350.0950. 17,239,976 shares were traded during trading, an increase of 139% from the average session volume of 7,209,344 shares. The stock had previously closed at $389.68.
Key UnitedHealth Group News
Here's some of the latest news about UNH:
- Positive Sentiment: UnitedHealth recently raised its 2026 adjusted earnings guidance for the third time, to at least $20.50 per share. Improved insurance margins and Optum’s scale offer potential support for longer-term growth. UnitedHealth Keeps Raising Guidance
- Negative Sentiment: CMS has proposed expanding Medicare Advantage audits and recovering overpayments dating back to 2018. The agency estimates the audits could recoup about $9 billion per payment year industry-wide; UnitedHealth’s potential share is unclear. The prospect of retroactive repayments is weighing on insurers’ outlooks. Why UnitedHealth and Other Medicare Advantage Insurers Are Falling
- Negative Sentiment: Political scrutiny is adding to the pressure: Sen. Elizabeth Warren called for breaking up healthcare conglomerates, including UnitedHealth, while Sen. Bernie Sanders renewed his push for Medicare for All. These proposals add uncertainty about the company’s business structure and future policy environment. Elizabeth Warren Targets CVS, UnitedHealth and Cigna
Analyst Upgrades and Downgrades
UNH has been the subject of several recent research reports. Royal Bank Of Canada lifted their price target on UnitedHealth Group from $478.00 to $498.00 and gave the stock an "outperform" rating in a research report on Tuesday, October 20th. New Street Research set a $402.00 price objective on UnitedHealth Group in a research note on Friday, October 9th. Stephens set a $500.00 target price on UnitedHealth Group in a report on Friday, October 16th. Robert W. Baird decreased their price target on UnitedHealth Group from $453.00 to $427.00 and set a "neutral" rating on the stock in a report on Wednesday, October 14th. Finally, Zacks Research downgraded UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research report on Monday, September 14th. Twenty analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company's stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $463.93.
Read Our Latest Research Report on UnitedHealth Group
UnitedHealth Group Stock Performance
The company has a quick ratio of 0.74, a current ratio of 0.74 and a debt-to-equity ratio of 0.66. The business has a 50 day simple moving average of $391.42 and a two-hundred day simple moving average of $366.73. The firm has a market cap of $313.69 billion, a PE ratio of 19.99, a price-to-earnings-growth ratio of 1.49 and a beta of 0.51.
UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its earnings results on Tuesday, October 13th. The healthcare conglomerate reported $4.69 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $4.14 by $0.55. The firm had revenue of $112.72 billion during the quarter, compared to analyst estimates of $111.31 billion. UnitedHealth Group had a net margin of 3.53% and a return on equity of 17.95%. The business's revenue was down .4% on a year-over-year basis. During the same period in the previous year, the firm earned $2.59 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. As a group, equities research analysts forecast that UnitedHealth Group Incorporated will post 20.61 earnings per share for the current fiscal year.
UnitedHealth Group Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 15th. Stockholders of record on Monday, December 7th will be given a dividend of $2.32 per share. The ex-dividend date of this dividend is Monday, December 7th. This represents a $9.28 dividend on an annualized basis and a dividend yield of 2.7%. UnitedHealth Group's dividend payout ratio (DPR) is 53.00%.
Insider Buying and Selling at UnitedHealth Group
In other news, CEO Patrick Conway sold 1,169 shares of UnitedHealth Group stock in a transaction that occurred on Friday, August 21st. The shares were sold at an average price of $390.00, for a total transaction of $455,910.00. Following the completion of the sale, the chief executive officer owned 15,328 shares of the company's stock, valued at approximately $5,977,920. The trade was a 7.09% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Corporate insiders own 0.19% of the company's stock.
Institutional Investors Weigh In On UnitedHealth Group
Several hedge funds have recently made changes to their positions in the company. BlackRock Inc. grew its position in UnitedHealth Group by 4.6% in the 2nd quarter. BlackRock Inc. now owns 76,863,061 shares of the healthcare conglomerate's stock valued at $31,946,594,000 after buying an additional 3,395,530 shares in the last quarter. State Street Corp grew its holdings in shares of UnitedHealth Group by 0.7% in the 2nd quarter. State Street Corp now owns 45,633,267 shares of the healthcare conglomerate's stock worth $18,966,555,000 after acquiring an additional 301,081 shares during the last quarter. Bank of New York Mellon Corp lifted its stake in UnitedHealth Group by 6.1% during the second quarter. Bank of New York Mellon Corp now owns 10,704,994 shares of the healthcare conglomerate's stock valued at $4,449,317,000 after buying an additional 616,723 shares in the last quarter. Wellington Management Group LLP boosted its stake in UnitedHealth Group by 5.8% in the 2nd quarter. Wellington Management Group LLP now owns 10,675,175 shares of the healthcare conglomerate's stock worth $4,436,923,000 after purchasing an additional 583,536 shares during the period. Finally, Fisher Asset Management LLC grew its holdings in shares of UnitedHealth Group by 19.2% during the third quarter. Fisher Asset Management LLC now owns 10,829,637 shares of the healthcare conglomerate's stock valued at $3,975,343,000 after buying an additional 1,747,368 shares in the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.
About UnitedHealth Group
(
Get Free Report)
UnitedHealth Group is a diversified health care company that provides health benefits and health services through two main businesses: UnitedHealthcare and Optum. UnitedHealthcare offers health insurance and related benefit plans to individuals, employers and government programs, including Medicare and Medicaid. Optum provides services across the health care system, including care delivery, pharmacy services, pharmacy benefit management, health technology and data analytics. Its businesses serve consumers, health care providers, employers, health plans and government organizations.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.